Viewing Study NCT06655051



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06655051
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-19

Brief Title: Single Plastic Stent Vs Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis
Sponsor: None
Organization: None

Study Overview

Official Title: Efficacy and Safety of Single Plastic Stent Compared with Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis a Single CenterProspectiveNon-inferiority Open Label Randomized Controlled Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ESSENCE
Brief Summary: The goal of this clinical trial is to compare the efficacy and safety of a single plastic stent versus a fully covered self-expanded metal stent in relieving benign biliary stricture secondary to chronic pancreatitis The main questions it aims to answer is

Whether the efficacy of a single plastic stent is non-inferior to that of a fully covered metal stent in patients with benign biliary stricture secondary to chronic pancreatitis

Participants will be randomly assigned to receive either a single plastic stent SPS placement or fully covered self-expanded metal stent placement treatment for 6 months and they will be followed up for 18 months
Detailed Description: Although a number of previous studies have shown that the drainage and dilation effect of a single plastic stent is limited for benign biliary stricture BBS secondary to chronic pancreatitis CP the poor management of CP itself in most studies may explain the unsatisfactory efficacy of a single biliary plastic stent in relieving CP secondary BBS Investigators believe that the effective management of CP is an important step to solve the BBS secondary to CP especially the effective removal of pancreatic duct stones the relief of pancreatic duct obstruction and the maintenance of pancreatic duct patency Previous data showed that in CP patients treated with ESWL combined with ERCP 724 could achieve complete removal of main pancreatic duct stones and 908 could achieve successful endoscopic decompression Under the premise of effectively removing the stones of the main pancreatic duct at the head of the pancreas and maintaining the patency of the pancreatic duct using a single plastic stent for stent drainage of BBS is effective and a single plastic stent has potential advantages such as lower stent displacement rate and cheaper Therefore investigators design a single-center prospective open-label randomized controlled non-inferiority trial to compare the effectiveness safety and cost-effectiveness of a single plastic stent and fcSEMS for the removal of CP secondary BBS under the premise that the primary disease ie CP itself was effectively managed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None